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Abstract
This paper is a study of factors influencing the rate of lipid peroxidation in beef heart submitochondrial particles induced
 .  .by NAD P H via the NADH-ubiquinone oxidoreductase Complex I of the respiratory chain. In accordance with earlier
observations, both NADH and NADPH initiated lipid peroxidation in the presence of ADP-Fe3q. The rate of the reaction,
measured as oxygen consumption and formation of thiobarbituric acid reactive substances, was biphasic as a function of
NADH concentration, reaching a maximum at low NADH concentrations and then declining. In contrast, the NADPH-ini-
tiated lipid peroxidation showed a monophasic concentration profile of hyperbolic character. Rotenone did not eliminate the
biphasicity of the NADH-induced reaction, indicating that this was not due to an antioxidant effect of reduced ubiquinone at
high NADH concentrations. This conclusion was further supported by the demonstration that extraction of ubiquinone from
the particles did not relieve the inhibition of lipid peroxidation by high NADH concentrations. However rhein, another
inhibitor of Complex I, eliminated the biphasicity, and even caused a substantial stimulation of the NADH-induced lipid
peroxidation in the particles upon extraction of ubiquinone by pentane. No similar effect occurred in the case of
NADPH-induced lipid peroxidation. Furthermore, rhein facilitated both NADH- and NADPH-induced lipid peroxidation
even in the absence of added ADP-Fe3q, in a fashion similar to that earlier reported with succinate in the presence of
theonyltrifluoroacetone. Based on these findings and measurements of the redox states of ubiquinone and cytochromes in
the presence of KCN and NADH or NADPH, it is concluded that Complex I may distinguish between electron input from
 .NADH and NADPH by differences in the site s of substrate binding and in the pathways and rates of NADH and NADPH
oxidation.
 .Keywords: Submitochondrial particle; Lipid peroxidation; Ubiquinone; Rhein; Bovine heart
Abbreviations: SMP, submitochondrial particles; UQ,
ubiquinone; TBARS, thiobarbituric acid reactive substances;
TTFA, theonyl trifluoroacetone; EFA, ethoxyformic acid;
UHDBT, 5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazol; PQQ,
pyrrol quinoline quinone.
)  .Corresponding author. Fax: q1 313 5771158; E-mail:
cplee@med.wayne.edu
1 Present address: Lilly Research Laboratories, Lilly Corporate
Center, Indianapolis, IN 46285, USA.
1. Introduction
Enzymic initiation of lipid peroxidation in beef
 .heart submitochondrial particles SMP occurs during
the oxidation of NADH or NADPH in the presence
w xof a suitable iron chelate 1–6 . Elucidation of the
reaction mechanism therefore requires identification
 .of the NAD P H-linked catalyst involved in this pro-
cess. The most commonly proposed catalyst is the
 .  .NADH-ubiquinone UQ oxidoreductase Complex I
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w xof the respiratory chain 2,3,5 . However, while the
oxidation of NADH by Complex I has been exten-
sively studied, the oxidation of NADPH by the same
complex is not well understood cf. reviews in refer-
w x.ences 7–9 . For a number of years it has been
shown that beef heart submitochondrial particles con-
sume NADPH at pH-7, in a rotenone-sensitive
manner, but at a much lower rate and with a higher
w xK than those found for NADH 10,11 . EPR studiesm
have demonstrated that NADPH incompletely re-
duces the iron–sulfur centers of Complex I as com-
w xpared with NADH 11–15 . On this basis, it has been
suggested that the NADPH-binding site is distinct
w xfrom that for NADH 10,11 . Albracht and co-workers
have proposed a model for the beef heart Complex I
in which the enzyme is a heterodimer with different
complements of iron–sulfur clusters, each of which
contains a nicotinamide nucleotide-binding site, but
w xonly one of which binds NADPH 13–15 .
w xIt has been shown by Takeshige et al. 1–4 that
NADH and NADPH can initiate lipid peroxidation in
beef heart SMP in the presence of ADP and Fe3q.
The process, followed by measurement of oxygen
consumption and of the formation of thiobarbituric
 .acid reactive substances TBARS , was found to be
biphasic as a function of the NADH concentration,
reaching a maximal rate at a low concentration of
NADH. In contrast, the NADPH-initiated lipid per-
oxidation revealed a monophasic concentration pro-
file of hyperbolic character, reaching a maximal rate
similar to that obtained at low NADH concentrations.
These observations were interpreted in terms of a
difference between the abilities of NADH and
NADPH to reduce UQ via the NADH-UQ oxido-
 .reductase Complex I of the respiratory chain, i.e., to
establish an adequate steady state concentration of
 .reduced UQ ubiquinol , the latter acting as an an-
tioxidant. An inhibition of lipid peroxidation was also
shown to occur upon the addition of succinate, which
reduced UQ via succinate-UQ oxidoreductase Com-
.plex II . When UQ was extracted from the particles
by pentane, the inhibition of lipid peroxidation by
succinate was abolished, and could be restored by
reincorporation of UQ into the particles. The role of
ubiquinol as a biological antioxidant has in recent
years extensively been studied in a number of labora-
 w x.tories see refs. 16–18 .
w xIn a previous paper 5 we have confirmed the
w xabove findings of Takeshige et al. 1–4 . However,
we found that the biphasic profile of the rate of lipid
peroxidation as a function of the NADH concentra-
tion also occurs in the presence of rotenone, which
inhibits the reduction of UQ via Complex I. Our
 .results indicated that factor s other than UQ may be
involved in the biphasic response of the ADP-Fe3q-
mediated lipid peroxidation system to increasing
NADH concentration, and that these factors, although
located before the rotenone-sensitive site of Complex
I, do not respond to NADPH. The purpose of the
present work was to characterize these factors, which
may be of interest for understanding the pro- and
anti-oxidant activities of the mitochondrial respira-
tory chain in controlling lipid peroxidation. Parts of
w xthis work have been communicated briefly 19,20 .
2. Materials and methods
 .Beef heart submitochondrial particles SMP were
w xprepared as described by Lee 21 , except that EDTA
was omitted from the sonication medium and 100 mg
cytochrome crmg mitochondrial protein was added
to the mitochondrial suspension before pH adjust-
ment and sonic disintegration.
UQ-depleted and UQ-replenished SMP were pre-
w xpared according to the methods of Szarkowska 22
w xas modified by Ernster et al. 23 . As the extraction
and replenishment procedures require lyophilized par-
ticles, control SMP were also lyophilized before re-
suspension in the incubation media. Native particles
were used as controls in studies not requiring UQ-de-
pleted or UQ-replenished SMP.
Lipid peroxidation was initiated by the addition of
ADP-Fe3q and NADH or NADPH. The detailed
experimental conditions are described in the Table
and Figure legends. Oxygen consumption was mea-
sured polarographically at 308C with a Clark-type
oxygen electrode in a 1 ml capacity chamber. Oxygen
uptake was recorded for 10 min unless otherwise
indicated. Subsequently, 0.5 ml of the reaction mix-
ture was removed from the oxygraph chamber, and
the enzyme reaction was terminated by the addition
of 0.5 ml of 30% trichloroacetic acid. TBARS were
then determined as a measure of the extent of lipid
peroxidation by the thiobarbituric acid colorimetric
w xtest 24 .
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Cytochrome contents were determined from re-
duced minus oxidized difference spectra recorded at
w xroom temperature, as described previously 5,25 us-
ing an Aminco DW2000 split beamrdual wavelength
spectrophotometer in the split beam mode. Amounts
 .of cytochromes reducible by NAD P H were related
to those reducible by dithionite, taking the latter as
100%.
Extents of reduction of UQ were determined after
incubation of SMP with 1 mM KCN and either
 .  .NADH 30–90 s , NADPH 1–8 min , or KBH4
 .1–2 min , in deoxygenated media under a nitrogen
stream, at 258C in a 1 ml cuvette. Protection of the
sample from the air during the incubation procedure
was critical for the success of the assay. UQ was then
extracted, and reduced and oxidized fractions were
determined by HPLC coupled to UV and electro-
w xchemical detection, as described by Lee et al. 26 .
 . 3q  .Fig. 1. Effect of rhein on NAD P H-dependent lipid peroxidation in SMP in the presence and absence of ADP-Fe measured as A
 .  .oxygen consumption and B TBARS formation: The reaction mixture consisted of 0.9 ml of 0.15 M KCl, 25 mM Tris-HCl pH 6.5 , 2.5
mM rotenone and 1.0 mg SMP protein. Others as indicated were: 40 mM rhein, and 1.0 mM ADPr10 mM Fe3q, and varying
 .  .  .  .concentrations of NADH left or NADPH right . Total volume: 1.0 ml; temperature: 308C. I,‘ control SMP, B,v control
 .  .SMPq rhein, ^,^ UQ-depleted SMP, ’,’ UQ-depleted SMPq rhein.
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Protein was determined by the method of Lowry et
w xal. 27 with bovine serum albumin as the standard.
Horse heart cytochrome c was obtained from
 .Sigma St. Louis, MO . All chemicals and reagents
were of the purest grades commercially available.
Pentane was distilled before used for UQ extraction
or replenishment. Glass-redistilled water was used
throughout all experiments.
3. Results
( )3.1. Effects of UQ depletion and rhein on NAD P H-
induced lipid peroxidation
Fig. 1 shows the effects of UQ depletion and rhein
on the lipid peroxidation activity of SMP in the
presence of rotenone, ADP-Fe3q, and varying con-
centrations of NADH or NADPH. In the case of
NADH the concentration profile was biphasic despite
the presence of rotenone, in accordance with earlier
w xobservations 5 . Removal of UQ from the particles
did not abolish the biphasicity even though the
.maximal activity was somewhat diminished , which
further supports the contention that the decrease in
lipid peroxidation activity upon increasing in the
Table 1
 .Effects of rhein on NAD P H-dependent lipid peroxidation in
SMP in the absence and presence of ADP-Fe3q
Condition n nmol O nmol TBARS2
consumed produced
NADHq rotenone
no addition 12 1.4"0.6 0.1"0.1
aqrhein 9 14.2"1.8 0.5"0.2
3qADP-Fe 85 25.9"6.9 1.8"0.9
3qqrheinqADP-Fe 5 27.4"8.8 1.3"0.6
NADPHq rotenone
no addition 5 0.0"0.0 0.1"0.0
qrhein 5 6.2"3.1 0.3"0.1
3qqADP-Fe 44 18.8"5.3 1.3"0.3
3qqrheinqADP-Fe 4 11.5"2.0 0.8"0.2
The reaction mixture consisted of 0.9 ml of 0.15 M KClr25 mM
 .Tris-HCl pH 6.5 , either 0.1 mM NADH or 0.2 mM NADPH,
and 1.0 mg SMP protein. Others when indicated: 2.5 mM
rotenone, 50 mM rhein. Total volume: 1.0 ml; temperature: 308C.
Average rates are reported. Statistical difference from value for
no addition: a P -0.01.
Table 2
 .Effects of rhein on NAD P H-dependent lipid peroxidation in
UQ-depleted SMP in the absence and presence of ADP-Fe3q
Condition n nmol O nmol TBARS2
consumed produced
NADHq rotenone
3qqADP-Fe 7 25.0"7.4 1.7"0.4
qrhein 7 45.1"10.4 2.3"0.6
3q a aqrheinqADP-Fe 2 120.9"1.8 7.6"0.7
b cqrheinqEDTA 3 15.3"6.3 0.6"0.1
NADPHq rotenone
3qqADP-Fe 5 14.4"5.7 1.0"0.3
qrhein 5 4.6"3.5 0.5"0.1
3qqrheinqADP-Fe 2 11.1"1.5 1.0"0.3
qrheinqEDTA 1 0.0 0.3
Experimental conditions were as in Table 1, except UQ-depleted
SMP was used. Statistical difference between the presence and
absence of rhein: a P -0.01. Statistical difference between the
presence and absence of 10 mM EDTA: b P -0.01; c P -0.05.
Table 3
NADH and NADPH oxidase activities of SMP




no inhibitor 7.5 26 777.5"270.6
no inhibitor 6.5 16 753.3"237.2
aqrhein 6.5 2 370.5"58.1
bqrotenone 6.5 3 4.3"0.0
bqEFA 6.5 1 0.0
bqantimycin 6.5 7 0.0"0.0
bqUHDBT 6.5 5 39.4"9.6
bqmyxothiazol 6.5 5 27.5"14.2
NADPH
ano inhibitor 7.5 4 0.0"0.0
no inhibitor 6.5 28 10.5"3.3
aqrhein 6.5 2 17.5"4.9
aqrotenone 6.5 4 2.2"2.2
qEFA 6.5 1 4.3
bqantimycin 6.5 10 7.9"3.4
qUHDBT 6.5 5 9.4"1.8
bmyxothiazol 6.5 3 4.4"0.1
The reaction mixture consisted of 0.9 ml medium, 0.2–0.4 mM
NADH or 0.4 mM NADPH, 0.1–0.5 mgrml SMP protein NADH
.  .oxidase and 1.0 mgrml SMP protein NADPH oxidase . Con-
centrations of other additions: 50 mM rhein, 2.5 mM rotenone,
0.6 mM EFA, 1 mM antimycin, 10 mM UHDBT, 2 mM
myxothiazol. Total volume: 1.0 ml; temperature: 308C. Maximal
rates are reported. Statistical differences from value with no
inhibitor at pH 6.5: a P -0.05, b P -0.01.
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NADH concentration was not due to a reduction of
UQ. However, rhein 4,5-dihydroxyanthraquinone-2-
.carboxylic acid , a competitive inhibitor of Complex
w xI with respect to NADH 28 , abolished the biphasic-
ity of the NADH concentration profile, and in the
UQ-depleted particles it even caused a 4- to 5-fold
stimulation of lipid peroxidation. In the case of
NADPH, depletion of UQ from the particles resulted
in a decrease in lipid peroxidation, and rhein had no
significant effect on either the control or the UQ-de-
pleted particles.
 .Rhein induced an NAD P H-dependent lipid per-
oxidation even in the absence of ADP-Fe3q, both in
the control and the UQ-depleted particles Tables 1
.and 2 , albeit to a lower extent than that found in the
presence of ADP-Fe3q. This effect, which was simi-
lar to that earlier described with succinate in the
 . w xpresence of theonyl trifluoroacetone TTFA 5 , was
inhibited by the iron chelator EDTA cf. Tables 1 and
.2 .
3.2. Comparison of NADH and NADPH oxidase ac-
ti˝ities
To explore the basis for the difference between the
NADH- and NADPH-induced lipid peroxidation sys-
tems, various parameters of the NADH and NADPH
oxidase activities of SMP were investigated.
Table 3 shows the respiratory rates with NADH or
NADPH as substrates. At pH 6.5, NADH induced
rapid and immediate oxygen uptake. The reaction
was catalyzed by the respiratory chain enzymes, as
demonstrated by its sensitivity to the Complex I
inhibitors rhein, rotenone and ethoxyformic acid
 .EFA , and by the inhibitors of ubiquinol-cytochrome
 .c oxidoreductase Complex III antimycin, 5-n-unde-
 .cyl-6-hydroxy-4,7-dioxobenzothiazol UHDBT and
myxothiazol. The uninhibited rate was unchanged at
pH 7.5.
NADPH was oxidized at -2% of the rate for
NADH at pH 6.5 and to no detectable extent at pH
 .7.5 Table 3 . A lag phase of 2–4 min preceded the
onset of oxygen uptake. The reaction was inhibited
by rotenone and myxothiazol, showing that it in-
volved Complexes I and III. Unlike the NADH oxi-
dase, however, it was only slightly inhibited by an-
timycin, and even stimulated by rhein.
3.3. Redox state of cytochromes
Table 4 summarizes data on the steady state levels
of reduced cytochromes b, c and a in SMP incubated
Table 4
 .Extent of reduction of cytochromes by NAD P H in the presence of respiratory inhibitors
 .Condition Cytochrome reduction % of dithionite-reducible
b c a
NADH
control 60.9"11.7 78.4"24.0 107.7"8.9
qrotenone 15.3"2.8 69.9"2.2 105.2"26.2
qantimycin 76.7"1.9 84.5"2.8 93.1"4.4
qUHDBT 50.6"16.5 72.8"18.9 81.4"14.0
qmyxothiazol 82.9"11.7 85.4"7.0 96.6"9.7
NADPH
control 37.4"15.1 77.2"11.4 104.8"14.4
qrotenone 1.1"1.1 61.1"18.6 79.7"10.9
qantimycin 62.1"7.5 81.0"11.3 72.4"21.1
qUHDBT 14.0"0.3 73.3"1.9 78.2"4.6
qmyxothiazol 50.0"10.6 62.2"2.2 70.2"18.8
 .The reaction mixture consisted of 0.9 ml of 0.15 M KClr2 mM Mops pH 6.5 , 1 mM KCN, 0.3 mM NADH and 1.0 mgrml SMP
protein. Concentrations of other additions: 2.5 mM rotenone, 2 mM antimycin, 2 mM myxothiazol, and 10 mM UHDBT.
( )M.A. Glinn et al.rBiochimica et Biophysica Acta 1318 1997 246–254 251
in the presence of KCN and NADH or NADPH, and
the changes in these levels upon the subsequent
addition of inhibitors of Complexes I or III. The
values are expressed as percent of dithionite-reduci-
ble cytochromes. In the presence of KCN alone, the
steady state levels of reduced cytochromes c and a
were approximately equal in the presence of NADH
and NADPH, approx. 80% and 100%, respectively.
The level of reduced cytochrome b was significantly
lower in the case of NADPH than that of NADH,
approx. 37% vs. 61%. It was also found that NADPH
reduced cytochromes c and a much more rapidly
than cytochrome b 50–70 s pre-steady state lag for
cytochromes c and a, vs. 460 seconds for b; with
.NADH, 25–35 s for all cytochromes; data not shown .
Among the inhibitors tested, rotenone sharply de-
creased the amount of cytochrome b reducible by
both nicotinamide nucleotides, but had much less
effect with respect to cytochromes c and a. An-
timycin, in contrast, increased the amount of cy-
tochrome b reducible by both NADH and NADPH,
in agreement with its proposed site of action on the Q
w xcycle 29 . Myxothiazol also increased, whereas
UHDBT decreased, the amount of cytochrome b
reducible by both nicotinamide nucleotides. These
findings suggested that the difference in the interac-
tion between Complex I as reduced by NADH or
NADPH and Complex III is primarily of kinetic
nature and may be governed by the redox state of
UQ.
3.4. Redox state of UQ
Support for the above contention was obtained by
measuring the steady state level of UQ in SMP
incubated with NADH or NADPH in the present of
 .KCN Table 5 . After addition of saturating concen-
 .trations of NADH 0.2–0.3 mM about 45% of the
total UQ was reduced, which was about one-half of
the amount reducible by KBH . At the same concen-4
tration of NADPH, there was no detectable amount of
reduced UQ. However, when the concentration of
NADH was decreased to non-saturating levels 9–15
.mM , the amount of reduced UQ decreased to about
14%. Likewise, there was a decrease even at saturat-
ing NADH concentration in the presence of rhein,
i.e., under conditions of limited electron input from
NADH. As expected, rotenone inhibited UQ reduc-
Table 5
 .Reduction of UQ by NAD P H
Reductant n nmol UQrmg % UQ reduced
protein
NADPH
0.2–0.3 mM 6 4.4"0.7 0.0"0.0
NADH
d9–15 mM 13 3.9"0.8 14.4"15.9
15 mM 2 3.7"0.2 45.7"1.0
a0.2–0.3 mM 20 3.8"0.8 47.6"14.7
0.3 mMqrhein 2 3.9"0.0 28.4"2.0
a,cKBH 4 4.4"0.6 91.4"3.44
bNone 1 5.8 0.0
Experimental conditions for SMP incubation, UQ extraction and
quantitation were as described in Section 2. The reaction mixture
consisted of nitrogenated 0.15 M KClr2 mM Mops buffer pH
.  .6.5 , 1 mM KCN, varying concentrations of NAD P H or KBH4
and 1.0–1.5 mgrml SMP protein. The concentration of rhein was
50 mM. Statistical differences from value for 0.3 mM NADH:
a P -0.01. b P -0.05. Statistical differences from value for 0.3
mM NADPH: c P -0.01, d P -0.05.
 .tion by NADH completely data not shown . It is
conceivable, therefore, that the lack of reduction of
UQ in the case of NADPH may be due to the very
slow electron input even at saturating NADPH con-
centration. Any electrons transferred to UQ may be
lost through autoxidation.
3.5. Effect of UQ depletion
Data summarized in Table 6 compare the effects of
UQ extraction and reincorporation on the NADH and
NADPH oxidase activities of SMP. In accordance
w xwith earlier reports 22,23 extraction of UQ caused
an inhibition of )95% of the NADH oxidase activ-
ity as compared to lyophilized controls. In contrast,
NADPH-supported oxygen uptake was not dimin-
ished upon removal of the bulk of UQ through
pentane extraction. One possibility for the lack of
effect of UQ extraction is again the low rate of
NADPH oxidation in the control, which did not
exceed that found with NADH after the pentane
treatment. However, the lag time before attainment of
maximal rate of oxygen uptake was much longer
 .)5 min when NADPH rather than NADH was the
substrate, regardless of the presence of UQ; this was
true even when the maximal rates obtained with the
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Table 6
Oxygen uptake induced by respiratory substrates in lyophilized
control, UQ-depleted and UQ-replenished SMP
 .Condition n nmol O rmin lag min2
per mg protein
NADH
control SMP 8 362.6"88.3 0.2"0.1
aUQ-depleted SMP 6 5.6"3.2 0.2"0.2
UQ-replenished SMP 2 123.0"3.0 0.2"0.2
NADPH
Control SMP 5 5.1"0.5 4.6"1.1
bUQ-depleted SMP 12 6.7"1.5 8.7"1.8
UQ-replenished SMP 4 3.1"0.1 8.6"0.4
The reaction mixture consisted of 0.9 ml of 0.15 M KClr2 mM
 .Mops pH 6.5 , 50 mgrml cytochrome c and 0.5–1.0 mgrml
SMP protein. Total volume: 1.0 ml; temperature: 308C. Maximal
rates are reported. Statistical differences from values for control
SMP: a P -0.01, b P -0.05.
two nicotinamide nucletides were similar, as was the
case with the UQ depleted SMP. The reason for this
lag, which was similar to that found for the attain-
ment of steady state level of cytochrome b reduction
 .by NADPH in the presence of KCN see above , is
unclear. However, it suggests that there is a differ-
ence between the mechanisms by which the NADH-
and NADPH-reduced Complex I interacts with UQ
and cytochrome b.
4. Discussion
The results presented here reveal some novel as-
pects of the role of Complex I of the mitochondrial
respiratory chain in both promoting and preventing
lipid peroxidation, i.e., in acting both as a pro- and an
anti-oxidant, depending on the prevailing conditions.
At low concentrations of NADH and in the presence
of ADP-Fe3q, lipid peroxidation proceeds at maximal
rate, which decreases upon increasing the NADH
concentration. This latter effect, as already pointed
out, cannot be due to an inhibition of lipid peroxida-
tion by ubiquinol, since it is also observed in the
presence of rotenone, which inhibits UQ reduction.
 .The present finding Fig. 1 that another inhibitor
of Complex I, rhein, abolishes this inhibition, indi-
cates that the decline of the rate of lipid peroxidation
 .at high concentration is caused by component s of
Complex I located between the rhein- and rotenone-
sensitive sites. It has been reported that pyrrolquino-
 .line quinone PQQ occurs in mitochondria, serving
as an electron carrier in Complex I at or near the
w xrotenone-sensitive site 30,31 , and that in its reduced
w xform it may act as an antoxidant 32 . Alternatively, it
may be that rhein, which is a quinone, may be
reduced by the flavoprotein component of Complex I
and give rise to a ‘redox cycling’ through the
semiquinone, with the formation of the superoxide
radical and the initiation of lipid peroxidation. Autox-
idation of ubisemiquinone to UQ and superoxide
induces TBARS formation at the S-3 iron sulfur
center of Complex II in the presence of thenoyltri-
 . w xfluoroacetone TTFA and succinate 5 . This redox
cycling and subsequent lipid peroxidation are pre-
w xvented if 50% of the UQ in SMP was reduced 33 . In
the case of Complex I, such an initiation may occur
via the nonheme iron component of Complex I adja-
cent to the flavoprotein and would thus explain the
findings that NADHq rhein can initiate lipid per-
oxidation in the absence of ADP-Fe3q and that this
 .process is inhibited by EDTA Table 2 . Reduced
rhein may also cause a non-enzymic reduction of UQ,
and would thus explain the very marked increase in
the rate of NADH and ADP-Fe3q-induced lipid per-
oxidation caused by rhein upon the extraction of UQ
 .from the particles Fig. 1 . Furthermore, it has been
w xshown 34,35 that extraction of SMP with pentane
also removes vitamin E, a potent inhibitor of lipid
peroxidation which may be regenerated by ubiquinol
w x36 and probably also by reduced rhein. These possi-
bilities may be explored in the future by using iso-
lated Complex I.
Concerning the differences in properties between
the NADH- and NADPH-induced lipid peroxidation
systems, these may be explained on the basis of the
heterodimeric model of Complex I proposed by Al-
w xbracht and associates 13–15 . According to this
 w x.model cf. ref. 15 , the NADPH-reactive monomer
lacks one of the iron sulfur centers and can interact
with UQ — and thereby with Complex III — only
by transferring electron to the distal iron sulfur cen-
ters of the other monomer, a reaction that is relatively
slow and requires an acidic pH. Interestingly, a simi-
lar requirement for acidic pH has earlier been re-
ported for the interaction of NADPH with lactate
w xdehydrogenase and alcohol dehydrogenase 37 , sug-
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gesting that the negative charge of the 3-phosphate
group of NADPH is responsible for the virtual lack
of reactivity of these enzymes with NADPH at pH
7.5. The same consideration may apply for the inter-
action of NADPH with Complex I. In any case, the
w xmodel of Albracht and associates 13–15 may ex-
plain the present findings that the reduction of UQ
and cytochrome b is the rate-limiting step in NADPH
oxidase. The lack of detectable reduction of UQ
 .Table 5 and the low steady state level of reduced
cytochrome b found with NADPH in the presence of
 .KCN Table 4 are consistent with this conclusion.
The reason for the long lag phase involved in the
reduction of cytochrome b is not clear, but may be
related to a back-flow of electrons from cytochrome
b to UQ via the Q cycle; notably, no similar lag is
found when NADH is oxidized at the same low rate
 .as NADPH cf. Table 6 . The increase in cytochrome
b reduction occurring upon the addition of antimycin
to the KCN-supplemented system may be due to the
inhibition of this back-flow. In fact, a similar phe-
nomenon has been observed with succinate or NADH
w xas substrate in UQ-depleted particles 23 or in parti-
cles in which the bulk of UQ has been destroyed
w xthrough lipid peroxidation 38 . In this connection, it
is of interest to refer to earlier conclusions by Rossi
w x w xet al. 39 and by Dooijewaard and Slater 40 that
UQ acts as a feedback regulator of succinate dehy-
drogenase and NADH dehydrogenase, respectively,
based on experiments with UQ-depleted preparations.
The common denominator in all of these systems is
the very low rate of electron input from the sub-
strates, NADPH, NADH or succinate, into Complex
III. However, whereas the examples of the UQ-defi-
cient systems represent artificial conditions, the
NADPH oxidase activity appears to be a native fea-
ture of the mitochondrial respiratory chain, the bio-
chemical and physiological functions of which de-
serve continued investigation.
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